• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mTOR 通路功能障碍是阿尔茨海默病的一个风险因素。

Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease.

机构信息

Neuropharmacology and Neurobiology, College of Medical and Dental Sciences, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, UK.

出版信息

Acta Neuropathol Commun. 2013 May 8;1:3. doi: 10.1186/2051-5960-1-3.

DOI:10.1186/2051-5960-1-3
PMID:24252508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3776211/
Abstract

BACKGROUND

The development of disease-modifying therapies for Alzheimer's disease is hampered by our lack of understanding of the early pathogenic mechanisms and the lack of early biomarkers and risk factors.We have documented the expression pattern of mTOR regulated genes in the frontal cortex of Alzheimer's disease patients. We have also examined the functional integrity of mTOR signaling in peripheral lymphocytes in Alzheimer's disease patients relative to healthy controls.

RESULTS

In the brain mTOR is seen to control molecular functions related to cell cycle regulation, cell death and several metabolic pathways. These downstream elements of the mTOR signaling cascade are deregulated in the brain of Alzheimer's disease patients well before the development of pathology. This dysregulation of the mTOR downstream signaling cascade is not restricted to the brain but appears to be systemic and can be detected in peripheral lymphocytes as a reduced Rapamycin response.

CONCLUSIONS

The dysfunction of the signaling pathways downstream of mTOR may represent a risk factor for Alzheimer's disease and is independent of the ApoE status of the patients.We have also identified the molecular substrates of the beneficial effects of Rapamycin on the nervous system. We believe that these results can further inform the development of clinical predictive tests for the risk of Alzheimer's disease in patients with mild cognitive impairment.

摘要

背景

由于我们对阿尔茨海默病的早期发病机制缺乏了解,也缺乏早期生物标志物和风险因素,因此疾病修饰疗法的发展受到了阻碍。我们已经记录了阿尔茨海默病患者大脑皮质中 mTOR 调节基因的表达模式。我们还研究了阿尔茨海默病患者与健康对照组外周血淋巴细胞中 mTOR 信号通路的功能完整性。

结果

mTOR 在大脑中被认为控制与细胞周期调控、细胞死亡和几种代谢途径相关的分子功能。阿尔茨海默病患者大脑中 mTOR 信号级联的这些下游元件在病理学发展之前就已经失调。mTOR 下游信号级联的这种失调不仅限于大脑,而且似乎是全身性的,可以在外周血淋巴细胞中检测到雷帕霉素反应降低。

结论

mTOR 信号通路下游的功能障碍可能代表阿尔茨海默病的一个风险因素,并且与患者的 ApoE 状态无关。我们还确定了雷帕霉素对神经系统有益作用的分子底物。我们相信,这些结果可以进一步为轻度认知障碍患者的阿尔茨海默病风险提供临床预测测试的开发依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/1920ac9e02a9/2051-5960-1-3-12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/f4389767da5c/2051-5960-1-3-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/3fcdd1ae8b00/2051-5960-1-3-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/fba11087d162/2051-5960-1-3-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/7c507b318bbc/2051-5960-1-3-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/e8d329f91e3a/2051-5960-1-3-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/39df3a588d46/2051-5960-1-3-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/16b63d700cda/2051-5960-1-3-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/3b58989c6629/2051-5960-1-3-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/4ede9430ed86/2051-5960-1-3-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/3099445621a4/2051-5960-1-3-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/bc73e4cedafa/2051-5960-1-3-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/1920ac9e02a9/2051-5960-1-3-12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/f4389767da5c/2051-5960-1-3-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/3fcdd1ae8b00/2051-5960-1-3-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/fba11087d162/2051-5960-1-3-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/7c507b318bbc/2051-5960-1-3-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/e8d329f91e3a/2051-5960-1-3-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/39df3a588d46/2051-5960-1-3-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/16b63d700cda/2051-5960-1-3-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/3b58989c6629/2051-5960-1-3-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/4ede9430ed86/2051-5960-1-3-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/3099445621a4/2051-5960-1-3-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/bc73e4cedafa/2051-5960-1-3-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/3776211/1920ac9e02a9/2051-5960-1-3-12.jpg

相似文献

1
Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease.mTOR 通路功能障碍是阿尔茨海默病的一个风险因素。
Acta Neuropathol Commun. 2013 May 8;1:3. doi: 10.1186/2051-5960-1-3.
2
Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment.mTOR 抑制可保护阿尔茨海默病和血管性认知障碍模型中的血脑屏障。
Am J Physiol Heart Circ Physiol. 2018 Apr 1;314(4):H693-H703. doi: 10.1152/ajpheart.00570.2017. Epub 2017 Dec 22.
3
Targeting the mTOR signaling network for Alzheimer's disease therapy.靶向mTOR信号网络用于阿尔茨海默病治疗。
Mol Neurobiol. 2014 Feb;49(1):120-35. doi: 10.1007/s12035-013-8505-8. Epub 2013 Jul 14.
4
mTOR signaling and Alzheimer's disease: What we know and where we are?mTOR信号传导与阿尔茨海默病:我们所知与现状
CNS Neurosci Ther. 2024 Apr;30(4):e14463. doi: 10.1111/cns.14463. Epub 2023 Sep 18.
5
Oxidative Stress and Decreased Mitochondrial Superoxide Dismutase 2 and Peroxiredoxins 1 and 4 Based Mechanism of Concurrent Activation of AMPK and mTOR in Alzheimer's Disease.氧化应激以及基于线粒体超氧化物歧化酶2、过氧化物还原酶1和4降低的阿尔茨海默病中AMPK和mTOR同时激活的机制
Curr Alzheimer Res. 2018;15(8):764-776. doi: 10.2174/1567205015666180223093020.
6
Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer's disease.轻度至重度阿尔茨海默病患者大脑中 mTOR 复合物 1 信号的差异激活。
J Alzheimers Dis. 2014;38(2):437-44. doi: 10.3233/JAD-131124.
7
Mammalian Target of Rapamycin at the Crossroad Between Alzheimer's Disease and Diabetes.雷帕霉素靶蛋白在阿尔茨海默病和糖尿病的十字路口。
Adv Exp Med Biol. 2019;1128:185-225. doi: 10.1007/978-981-13-3540-2_10.
8
Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain.PI3K/Akt/mTOR轴在唐氏综合征大脑中的神经病理学作用。
Biochim Biophys Acta. 2014 Jul;1842(7):1144-53. doi: 10.1016/j.bbadis.2014.04.007. Epub 2014 Apr 13.
9
Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease.将衰老控制与阿尔茨海默病联系起来的血管性mTOR依赖机制。
Biochim Biophys Acta. 2016 May;1862(5):992-1007. doi: 10.1016/j.bbadis.2015.11.010. Epub 2015 Nov 27.
10
Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer's disease.GPCR 调节阿尔茨海默病中 MAPK 和 mTOR 通路的潜力。
Prog Neurobiol. 2017 Feb-Mar;149-150:21-38. doi: 10.1016/j.pneurobio.2017.01.004. Epub 2017 Feb 9.

引用本文的文献

1
Unraveling the role of proteins in dementia: insights from two UK cohorts with causal evidence.揭示蛋白质在痴呆症中的作用:来自两个具有因果证据的英国队列研究的见解。
Brain Commun. 2025 Mar 3;7(2):fcaf097. doi: 10.1093/braincomms/fcaf097. eCollection 2025.
2
Homocysteine Thiolactone Detoxifying Enzymes and Alzheimer's Disease.同型半胱氨酸硫内酯解毒酶与阿尔茨海默病。
Int J Mol Sci. 2024 Jul 25;25(15):8095. doi: 10.3390/ijms25158095.
3
The Brain-Gut Axis, an Important Player in Alzheimer and Parkinson Disease: A Narrative Review.脑-肠轴:阿尔茨海默病和帕金森病中的重要角色——一篇叙述性综述

本文引用的文献

1
The genetics of Alzheimer disease.阿尔茨海默病的遗传学。
Cold Spring Harb Perspect Med. 2012 Oct 1;2(10):a006296. doi: 10.1101/cshperspect.a006296.
2
Alzheimer's disease and the amyloid cascade hypothesis: a critical review.阿尔茨海默病与淀粉样蛋白级联假说:批判性综述
Int J Alzheimers Dis. 2012;2012:369808. doi: 10.1155/2012/369808. Epub 2012 Mar 17.
3
Microarray gene expression analysis of fixed archival tissue permits molecular classification and identification of potential therapeutic targets in diffuse large B-cell lymphoma.
J Clin Med. 2024 Jul 15;13(14):4130. doi: 10.3390/jcm13144130.
4
Loss of Mitochondrial Tusc2/Fus1 Triggers a Brain Pro-Inflammatory Microenvironment and Early Spatial Memory Impairment.线粒体 TusC2/Fus1 的缺失会引发大脑促炎微环境和早期空间记忆损伤。
Int J Mol Sci. 2024 Jul 5;25(13):7406. doi: 10.3390/ijms25137406.
5
Our Hidden Enemy: Ultra-Processed Foods, Inflammation, and the Battle for Heart Health.我们隐藏的敌人:超加工食品、炎症与心脏健康保卫战
Cureus. 2023 Oct 22;15(10):e47484. doi: 10.7759/cureus.47484. eCollection 2023 Oct.
6
Synthetic and Natural Bioactive Molecules in Balancing the Crosstalk among Common Signaling Pathways in Alzheimer's Disease: Understanding the Neurotoxic Mechanisms for Therapeutic Intervention.合成与天然生物活性分子在阿尔茨海默病常见信号通路串扰平衡中的作用:理解治疗干预的神经毒性机制
ACS Omega. 2023 Oct 20;8(43):39964-39983. doi: 10.1021/acsomega.3c05662. eCollection 2023 Oct 31.
7
Deletion of the Homocysteine Thiolactone Detoxifying Enzyme Bleomycin Hydrolase, in Mice, Causes Memory and Neurological Deficits and Worsens Alzheimer's Disease-Related Behavioral and Biochemical Traits in the 5xFAD Model of Alzheimer's Disease.在 5xFAD 阿尔茨海默病模型小鼠中敲除同型半胱氨酸硫内酯解毒酶博来霉素水解酶导致记忆和神经功能缺陷,并加重阿尔茨海默病相关的行为和生化特征。
J Alzheimers Dis. 2023;95(4):1735-1755. doi: 10.3233/JAD-230578.
8
New Insights into the Roles of p53 in Central Nervous System Diseases.p53 在中枢神经系统疾病中的作用的新见解。
Int J Neuropsychopharmacol. 2023 Jul 31;26(7):465-473. doi: 10.1093/ijnp/pyad030.
9
Proteomic Exploration of Paraoxonase 1 Function in Health and Disease.对健康和疾病中对氧磷酶 1 功能的蛋白质组学探索。
Int J Mol Sci. 2023 Apr 24;24(9):7764. doi: 10.3390/ijms24097764.
10
Depletion of Paraoxonase 1 (Pon1) Dysregulates mTOR, Autophagy, and Accelerates Amyloid Beta Accumulation in Mice.耗竭对氧磷酶 1(Pon1)可使雷帕霉素靶蛋白(mTOR)失调、自噬,并加速小鼠淀粉样β肽的积累。
Cells. 2023 Feb 26;12(5):746. doi: 10.3390/cells12050746.
固定存档组织的基因表达微阵列分析可实现弥漫性大 B 细胞淋巴瘤的分子分类和潜在治疗靶点的鉴定。
J Mol Diagn. 2012 May-Jun;14(3):223-32. doi: 10.1016/j.jmoldx.2012.01.008. Epub 2012 Mar 22.
4
Neuroimaging results impose new views on Alzheimer's disease--the role of amyloid revised.神经影像学研究结果为阿尔茨海默病带来新视角——淀粉样蛋白的作用被修正。
Mol Neurobiol. 2012 Feb;45(1):153-72. doi: 10.1007/s12035-011-8228-7. Epub 2011 Dec 27.
5
Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.前额叶皮层转录本的协同变化先于阿尔茨海默病的神经病理学变化。
Brain. 2010 Dec;133(Pt 12):3699-723. doi: 10.1093/brain/awq258. Epub 2010 Oct 1.
6
Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease.mTOR 通路失调介导阿尔茨海默病小鼠模型中突触可塑性的损伤。
PLoS One. 2010 Sep 20;5(9):e12845. doi: 10.1371/journal.pone.0012845.
7
Impact of RNA degradation on gene expression profiling.RNA 降解对基因表达谱的影响。
BMC Med Genomics. 2010 Aug 9;3:36. doi: 10.1186/1755-8794-3-36.
8
Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword?哺乳动物雷帕霉素靶蛋白(mTOR)调控细胞死亡和癫痫发生:一把双刃剑?
Cell Cycle. 2010 Jun 15;9(12):2281-5. doi: 10.4161/cc.9.12.11866.
9
Gene expression reveals overlap between normal aging and Alzheimer's disease genes.基因表达揭示了正常衰老和阿尔茨海默病基因之间的重叠。
Neurobiol Aging. 2011 Dec;32(12):2319.e27-34. doi: 10.1016/j.neurobiolaging.2010.04.019. Epub 2010 Jun 8.
10
Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway.开发用于后天性癫痫的抗癫痫药物:靶向雷帕霉素哺乳动物靶点(mTOR)通路
Mol Cell Pharmacol. 2009 Jan 1;1(3):124-129. doi: 10.4255/mcpharmacol.09.16.